Universitätsmedizin Rostock

Hospital


Location: Rostock, Germany (DE) DE

ISNI: 0000000097370454

ROR: https://ror.org/04dm1cm79

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Informal caregiving in amyotrophic lateral sclerosis (Als): A high caregiver burden and drastic consequences on caregivers’ lives (2021) Schischlevskij P, Cordts I, Günther R, Stolte B, Zeller D, Schröter C, Weyen U, et al. Journal article Prescription patterns of antiseizure drugs in tuberous sclerosis complex (TSC)-associated epilepsy: a multicenter cohort study from Germany and review of the literature (2021) Strzelczyk A, Grau J, Bast T, Bertsche A, Bettendorf U, Hahn A, Hartmann H, et al. Journal article, Review article Scoring functions for drug-effect similarity (2021) Struckmann S, Ernst M, Fischer S, Mah N, Fuellen G, Möller S Journal article Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibition (2021) Knispel S, Gassenmaier M, Menzies AM, Loquai C, Johnson DB, Franklin C, Gutzmer R, et al. Journal article Generation "Social Media": use of modern media to gain information regarding sports injuries (2021) Enz A, Schöffl VR, Simon M, Back DA, Tischer T, Lutter C Journal article TRABECULAR SUBCHONDRAL BONE ANALYSIS OF THE DISTAL RADIUS AT ULTRA-HIGH FIELD (7T) MRI: COMPARISON WITH 3T MRI AND RADIOGRAPHY (2021) Jarraya M, Heiß R, Duryea J, Nagel AM, Lynch JA, Guermazi A, Weber MA, et al. Conference contribution Adjuvant melanoma treatment: real-world data from the DACH region (2021) Schumann K, Mangana J, Dummer R, Sindrilaru M, Reinhardt L, Meier F, Gutzmer R, et al. Conference contribution Real-world efficacy of ribociclib plus aromatase inhibitor/fulvestrant, or endocrine monotherapy, or chemotherapy as first-line treatment in women with HR-positive, HER2-negative locally advanced or metastatic breast cancer: Third interim analysis from the RIBANNA study (2021) Wockel A, Brucker C, Decker T, Falbrede J, Forstbauer H, Gohler T, Hoffmann O, et al. Conference contribution Regulatory Requirements of Radiopharmaceuticals in Germany: The Specialist Society in official Dialog (2021) Patt M, Kuwert T, Luster M, Krause BJ, Solbach C Journal article, Editorial Appendicitis during the COVID-19 lockdown: results of a multicenter analysis in Germany. (2021) Willms AG, Oldhafer KJ, Conze S, Thasler WE, Von Schassen C, Hauer T, Huber T, et al. Journal article